Familial CLL: genes and environment.
Lynn R Goldin, Susan L Slager
https://pubmed.ncbi.nlm.nih.gov/18024649/Actively Recruiting
Led by Mayo Clinic · Updated on 2026-11-02
3000
Participants Needed
1
Research Sites
N/A
Total Duration
Blood and lymph node cancers, including lymphoma, leukemia, and myeloma, involve uncontrolled growth of white blood cells and have many subtypes such as chronic lymphocytic leukemia and non-Hodgkin lymphoma. These cancers tend to cluster in families, prompting researchers to study the roles of genetics and environmental exposures in their development. This observational study is conducted by the Mayo Clinic to better understand these contributing factors. Participants in this study are observed without receiving any experimental treatments. The study focuses on families with at least two living blood-related members affected by lymphoproliferative disorders. Data collection involves monitoring these families over time to assess the ongoing risk of blood or lymphoma-related cancers. During the study, participants provide information that helps researchers evaluate genetic and environmental influences on these cancers. The main outcome measure is the ongoing risk of developing blood or lymphoma cancers. The study allows healthy volunteers and plans to continue through December 2029, with participants involved for varied lengths based on family and disease characteristics.
CONDITIONS
Family Study of Lymphoproliferative Disorders
C
Catie Erding
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Mayo Clinic
Lead Sponsor
National Cancer Institute (NCI)
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person or remote)
Duration - Up to 25 years
Participants provide family medical history and other information to help researchers study genetic and environmental risks for blood and lymph node cancers.
Periodic data collection and questionnaires
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Have more questions? Get in touch with our team for quick support
Lynn R Goldin, Susan L Slager
https://pubmed.ncbi.nlm.nih.gov/18024649/Susan L Slager, Neil E Kay, Zachary S Fredericksen...
https://pubmed.ncbi.nlm.nih.gov/18021089/Scott J Hebbring, Susan L Slager, Narendranath Epperla...
https://pubmed.ncbi.nlm.nih.gov/23287625/Lynn R Goldin, Mark C Lanasa, Susan L Slager...
https://pubmed.ncbi.nlm.nih.gov/20738309/M C Lanasa, S D Allgood, S L Slager...
https://pubmed.ncbi.nlm.nih.gov/21617698/Susan L Slager, Neil E Kay
https://pubmed.ncbi.nlm.nih.gov/19778840/Susan L Slager, Christine F Skibola, Maria Chiara Di Bernardo...
https://pubmed.ncbi.nlm.nih.gov/22700719/Susan L Slager, Lynn R Goldin, Sara S Strom...
https://pubmed.ncbi.nlm.nih.gov/20332261/Gabrielle S Sellick, Lynn R Goldin, Ruth W Wild...
https://pubmed.ncbi.nlm.nih.gov/17687107/Susan L Slager, Nicola J Camp, Lucia Conde...
https://pubmed.ncbi.nlm.nih.gov/23025533/Mayo Clinic
Lead Sponsor
National Cancer Institute (NCI)
Collaborating Sponsor